[{"AccountsPayableCurrent_0_Q3_USD":15575000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-287000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-12000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-635000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-178000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_3_Q3_USD":-348000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_1_Q3_USD":-166000.0,"OtherAssetsNoncurrent_0_Q3_USD":16419000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":32238000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":36696000.0,"OperatingIncomeLoss_3_Q3_USD":-279173000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":471000.0,"OperatingIncomeLoss_1_Q3_USD":-89828000.0,"NetIncomeLoss_1_Q3_USD":-72998000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-284351000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-264429000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":32827000.0,"LiabilitiesCurrent_0_Q3_USD":135933000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1484801000.0,"Liabilities_0_Q3_USD":551127000.0,"InvestmentsFairValueDisclosure_0_Q3_USD":1004715000.0,"InvestmentIncomeInterest_3_Q3_USD":1488000.0,"InvestmentIncomeInterest_1_Q3_USD":408000.0,"NetIncomeLoss_3_Q3_USD":-331567000.0,"InventoryWorkInProcess_0_Q3_USD":9546000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-433000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-1277000.0,"StockholdersEquity_0_Q3_USD":933674000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":160551000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":53883000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":268017000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":81647000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1951143000.0,"RestrictedCashNoncurrent_0_Q3_USD":2001000.0,"RestrictedCashCurrent_0_Q3_USD":10000000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":374140000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":113417000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-415000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":119069000.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":-350000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":583997000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":33177000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":69193000.0,"PreferredStockValue_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":25000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":57045000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":917409000.0,"PaymentsForProceedsFromOtherInvestingActivities_3_Q3_USD":487000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":83318000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":67875363.0,"InventoryNet_0_Q3_USD":15191000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":130869000.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_1_Q3_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":204243000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":539579000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q3_USD":918659000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":123000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":96000.0,"AvailableForSaleSecurities_0_Q3_USD":918632000.0,"AssetsCurrent_0_Q3_USD":846884000.0,"Assets_0_Q3_USD":1484801000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":8304317.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_3_Q3_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":8317206.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":26990000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":78324000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":27005000.0,"AdditionalPaidInCapital_0_Q3_USD":2884695000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":54000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q3_USD":81000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q3_USD":-27000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":109660000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-4499000.0,"AccountsReceivableNetCurrent_0_Q3_USD":25383000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":78430000.0,"InventoryFinishedGoods_0_Q3_USD":5645000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":197538000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-516755000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":6979000.0,"IncreaseDecreaseInInventories_3_Q3_USD":2127000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":2362000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":1024000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":182000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-330543000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-72816000.0,"Goodwill_0_Q3_USD":44406000.0,"EquitySecuritiesFvNiGainLoss_3_Q3_USD":-25963000.0,"EquitySecuritiesFvNiGainLoss_1_Q3_USD":25702000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":209539000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":55164000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-4.91,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.08,"DepreciationDepletionAndAmortization_3_Q3_USD":9705000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":33306000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-332202000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-73176000.0,"CommonStockValue_0_Q3_USD":68000.0,"CommonStockSharesOutstanding_0_Q3_shares":67961963.0,"CommonStockSharesIssued_0_Q3_shares":67961963.0,"CommonStockSharesAuthorized_0_Q3_shares":250000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_Q3_USD":-802000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":67533671.0,"Ticker":"RARE","CIK":"1515673","name":"ULTRAGENYX PHARMACEUTICAL INC.","OfficialName":"Ultragenyx Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5418950849.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211103"}]